Video | Agriculture | Confidence | Economy | Energy | Employment | Finance | Media | Property | RBNZ | Science | SOEs | Tax | Technology | Telecoms | Tourism | Transport | Search

 

Kathmandu shares rise 9.3% on strong FY result


By Rebecca Howard

Sept. 18 (BusinessDesk) - Kathmandu Holdings shares rose 9.3 percent after the company reported annual profit at the top end of its guidance, including a standout performance in the US.

The outdoor equipment chain said net profit was $57.6 million in the year ended July 31, versus $50.7 million in the prior year. Total sales rose 9.7 percent to $545.6 million.

In August the company said it expected net profit of $56.5-$58 million.

“The key driver was a positive contribution from the Australian business and rapid sales and profit growth from Oboz in North America and increased penetration of the online channel,” chief executive Xavier Simonet said on a media conference call.

Oboz, acquired in April 2018, saw full-year pro-forma sales growth of 30 percent with earnings before interest and tax up 38.6 percent on a pro-forma basis. North American sales were $64 million while ebit was $9.6 million, it said.

“The foray into North America looks to be going very, very well and that’s a real positive for the company,” said Hamilton Hindin Greene investment advisor Grant Davies.

Davies said investors were also likely cheered by news the online segment was also looking positive, with those sales now comprising 10.1 percent of direct-to-consumer sales, up from 9.4 percent a year earlier.

“Particularly for Kathmandu, which has relied so heavily on their stores in the past, to see that picking up a bit of traction is another positive for them,” Davies said.

The stock last traded at $3.05, the highest level since October last year.

Same-store sales growth lifted 0.6 percent although Australia fared better than New Zealand.

Australian same-store growth was up 2.7 percent while in New Zealand it fell 3.9 percent.

Australia makes up 66 percent of the business while New Zealand makes up 25 percent.

Kathmandu said the New Zealand market is “more mature” and therefore more price sensitive. Also, a late start to winter had an impact on sales, it said.

Overall, gross margin slipped to 60.9 percent from 63.4 percent. In Australia, it was 65.4 percent versus 65.9 percent in the prior year. In New Zealand, it was 59.6 percent versus 60.5 percent. The North American gross margin was 40.8 percent down from 41.8 percent.

Davies said that considering the Oboz business unit operates at lower margins, “margins were holding up ok.”

Kathmandu will pay a final dividend of 12 cents a share versus 11 cents a share in the prior year. The record date is Sep. 30 while the payment date is Oct. 11. Davies said the dividend was higher than some analysts had expected, which is also likely helping to push the share price higher.

The company provided no guidance but, in the seven weeks to Sep. 15, group same-store sales grew 6.1 percent at constant exchange rates, but at lower gross margin. Australia same-store sales grew 4 percent and New Zealand same-store sales rose 11.7 percent.


© Scoop Media

 
 
 
Business Headlines | Sci-Tech Headlines

 

$7.5 Billion Surplus: Government Accounts "Show Strong Economy"

“The surplus and low levels of debt show the economy is in good shape. This allows the Government to spend more on infrastructure and make record investments in health and education,” Grant Robertson says. More>>

ALSO:

New OIO Application Trumps Judicial Review: OceanaGold Cleared To Buy Land For Waihi Tailings Expansion

In a surprise turnaround, the government has given OceanaGold a greenlight to buy land to expand its Waihi mine after the application was previously turned down by Land Information Minister Eugenie Sage. More>>

ALSO:

Christchurch Rebuild: Fletcher Sued For $7.5m Over Justice Precinct

Fletcher Building is being sued for $7.5 million by utilities contractor Electrix, one of the subcontractors on the Christchurch Justice and Emergency Services Precinct. More>>

Three New Drugs: PHARMAC Signs Bundle Deal For More Cancer Medicines

420 New Zealanders with lung cancer, breast cancer, multiple sclerosis and respiratory disease will benefit each year from a bundle deal PHARMAC has finalised with a medicine supplier. More>>

ALSO:

"Levels Playing Field": Government Responds To Electricity Price Review

The changes announced today include: • Supporting new and independent retailers by requiring the big power companies to sell into the wholesale market at affordable rates. • Extending discount rates to all customers • A pilot scheme to help customers who have not switched power providers before to shop around for better deals... More>>

ALSO: